Medtronic has also recently acquired Ventor Technologies, a developer of percutaneous, catheter-based transapical aortic valve replacement products.
Bill Hawkins, chairman and CEO of Medtronic, said: “These acquisitions position us as a leader in one of the most exciting new markets in medical devices. We expect a significant number of people with aortic stenosis to benefit from these break-through technologies. We have the scale and expertise to accelerate the use of these life-saving technologies.”